Results 51 to 60 of about 825 (170)

Efficacy and safety of blonanserin versus other antipsychotics: a review [PDF]

, 2017
Although many atypical antipsychotics are available, there is a need of an atypical antipsychotic effective in all symptom domains of schizophrenia and well tolerated especially for side effects like extrapyramidal side effects, weight gain and blood ...
Patil, Anant D.
core  

Effect of antipsychotics on breast tumors by analysis of the Japanese Adverse Drug Event Report database and cell-based experiments

Journal of Pharmaceutical Health Care and Sciences, 2021
Background Since antipsychotics induce hyperprolactinemia via the dopamine D2 receptor, long-term administration may be a risk factor for developing breast tumors, including breast cancer. On the other hand, some antipsychotic drugs have been reported to
Tae Maeshima, Ryosuke Iijima, Machiko Watanabe, Satoru Yui, Fumio Itagaki   +4 more
doaj   +1 more source

Reduced sociability in a prenatal immune activation model: Modulation by a chronic blonanserin treatment through the amygdala-hippocampal axis

, 2023
The environmental disturbances in a critical neurodevelopmental period exert organizational effects on brain intrinsic plasticity including excitatory and inhibitory (E/I) neurotransmission those can cause the onset of psychiatric illness.
Chiaki Kawanishi, Marchisella, Francesca, Nishimura, Emi, Hashimoto, Eri, Francesca Marchisella, Deriha, Kenta, Eri Hashimoto, Tayama, Masaya, Kenta Deriha, Kawanishi, Chiaki, Emi Nishimura, Hashiguchi, Hanako, Ishii, Takao, Marco A. Riva, Ukai, Wataru, Hanako Hashiguchi, Wataru Ukai, Riva, Marco A., Masaya Tayama, Takao Ishii   +19 more
core   +1 more source

A Japanese Pregnant Woman With Treatment‐Resistant Schizophrenia Who Continued Clozapine With Blood Concentration Monitoring During the Perinatal Period and Had a Healthy Baby: A Case Report

Neuropsychopharmacology Reports, Volume 45, Issue 4, December 2025.
This is the first case in Japan where a patient with treatment‐resistant schizophrenia planned marriage and pregnancy while on clozapine treatment, continued clozapine with blood level monitoring throughout the perinatal period and had a healthy baby.
Mariko Tsukiji, Kaori Yamazaki, Yusuke Nakata, Tsuyoshi Sasaki, Keita Idemoto, Kazuki Okada, Shingo Yamazaki, Akiko Omoto, Kaori Koga, Tomihisa Niitsu, Itsuko Ishii   +10 more
wiley   +1 more source

Characteristics and management of headache among psychiatric outpatients at a Japanese general hospital: A retrospective study with an exploratory CGRP case series

Psychiatry and Clinical Neurosciences Reports, Volume 4, Issue 4, December 2025.
Abstract Aim Headache is one of the most frequent somatic complaints in psychiatric practice and is often attributed to underlying mental disorders. However, primary headache disorders—particularly migraine and tension‐type headache (TTH)—commonly coexist with psychiatric conditions.
Kyohei Otani, Nobuyasu Imbe, Ryota Shindo   +2 more
wiley   +1 more source

Impact of antipsychotics, antiparkinsonian drugs, and anthraquinone stimulant laxatives on severe constipation in patients with schizophrenia

Psychiatry and Clinical Neurosciences Reports, Volume 4, Issue 4, December 2025.
This study investigated risk factors for severe constipation in patients with schizophrenia receiving pharmacological treatment. A retrospective analysis of over 4000 inpatients revealed that high‐dose use of clozapine, haloperidol, antiparkinsonian drugs, and anthraquinone stimulant laxatives significantly increased the risk.
Toshiaki Nadaya, Tokuya Inaguma, Tomoko Nagao, Takuto Ishida   +3 more
wiley   +1 more source

A protocol for systematic review and meta analysis of clinical evaluation of cognitive function in patients with schizophrenia treated with blonanserin

, 2021
As a new type of antipsychotic drug, different from most atypical antipsychotic drugs, blonanserin has a slightly higher affinity for dopamine D2 receptor than 5-HT2A receptor, and is an antagonist of both and dopamine D3 receptor. However, it had almost
Yefeng Yuan, Xiangli Dong, Qing Zou, Qin Yuan, Xiaoxiao Wang, SunWeiming   +5 more
core   +1 more source

The Concise Guide to PHARMACOLOGY 2025/26: G protein‐coupled receptors

British Journal of Pharmacology, Volume 182, Issue S1, Page S24-S151, December 2025.
The Concise Guide to Pharmacology 2025/26 marks the seventh edition in this series of biennial publications in the British Journal of Pharmacology. Presented in landscape format, the guide provides a comparative overview of the pharmacology of drug target families. The concise nature of the Concise Guide refers to the style of presentation, being clear,
Stephen P. H. Alexander, Anthony P. Davenport, Eamonn Kelly, Alasdair J. Gibb, Alistair A. Mathie, Chloe J. Peach, Emma L. Veale, Jane F. Armstrong, Elena Faccenda, Simon D. Harding, Christopher Southan, Jamie A. Davies, Maria Pia Abbracchio, George R. Abraham, Alexander Agoulnik, Wayne Alexander, Khaled Al‐hosaini, Magnus Bäck, Jillian G. Baker, Nicholas M. Barnes, Ross Bathgate, Jean‐Martin Beaulieu, Annette G. Beck‐Sickinger, Maik Behrens, Kirstie A. Bennett, Kenneth E. Bernstein, Bernhard Bettler, Nigel J. M. Birdsall, Victoria A. Blaho, Pascal Bonaventure, Francois Boulay, Corinne Bousquet, Hans Bräuner‐Osborne, Andrew J. Brown, Geoffrey Burnstock, Marta Busnelli, Girolamo Caló, Vanni Caruso, Justo P. Castaño, Kevin J. Catt, Stefania Ceruti, Paul Chazot, Nan Chiang, Bice Chini, Arthur Christopoulos, Jerold Chun, Antonia Cianciulli, Olivier Civelli, Lucie H. Clapp, Réjean Couture, Helen M. Cox, Zsolt Csaba, Claes Dahlgren, Frank M. Dautzenberg, Gordon Dent, Steven D. Douglas, Pascal Dournaud, Margarita L. Dubocovich, Satoru Eguchi, Emanuel Escher, Edward J. Filardo, Tung Fong, Huamei Fu Forsman, Marta Fumagalli, Raul R. Gainetdinov, Michael L. Garelja, Marc de Gasparo, Florence Gbahou, Craig Gerard, Marvin Gershengorn, Michelle Glass, David E. Gloriam, Fernand Gobeil, Theodore L. Goodfriend, Cyril Goudet, Lukas Grätz, Karen J. Gregory, Christian Gruber, Andrew L. Gundlach, Jörg Hamann, Julien Hanson, Deborah S. Hartman, Richard L. Hauger, Debbie L. Hay, Akos Heinemann, Laura Heitman, Deron R. Herr, Morley D. Hollenberg, Nicholas D. Holliday, Birgitte Holst, Mastgugu Horiuchi, Daniel Hoyer, László Hunyady, Ahsan Husain, Adriaan P. IJzerman, Tadashi Inagami, Paul A. Insel, Kenneth A. Jacobson, Laura H. Jacobson, Robert T. Jensen, Ralf Jockers, Deepa Jonnalagadda, Sadashiva Karnik, Klemens Kaupmann, Jacqueline Kemp, Charles Kennedy, Yasuyuki Kihara, Julia Kinsolving, Takio Kitazawa, Pawel Kozielewicz, Hans‐Jürgen Kreienkamp, Jyrki P. Kukkonen, Luxmichan Laishram, Tobias Langenhan, Christopher J. Langmead, Dan Larhammar, Katie Leach, Davide Lecca, John D. Lee, Susan E. Leeman, Jérôme Leprince, Rob Leurs, Xaria X. Li, Ines Liebscher, Stephen J. Lolait, Amelie Lupp, Robyn Macrae, Janet J. Maguire, Davide Malfacini, Maurice Manning, Davide Marangon, Kirill Martemyanov, Jean Mazella, Craig A. McArdle, Shlomo Melmed, Martin C. Michel, Laurence J. Miller, Vincenzo Mitolo, Bernard Mouillac, Christa E. Müller, Philip M. Murphy, Jean‐Louis Nahon, Richard R. Neubig, Tony Ngo, Xavier Norel, Duuamene Nyimanu, Anne‐Marie O’Carroll, Stefan Offermanns, Maria Antonietta Panaro, Marc Parmentier, Nicole Perry‐Hauser, Roger G. Pertwee, Jean‐Philippe Pin, Eric R. Prossnitz, Helena Chengxue Qin, Mark Quinn, Stefano Raffaele, Rithwik Ramachandran, Manisha Ray, Rainer K. Reinscheid, Alejandro Romeral Buzón, Philippe Rondard, Mette M. Rosenkilde, G. Enrico Rovati, Chiara Ruzza, Gareth J. Sanger, Nicole Scholz, Torsten Schöneberg, Gunnar Schulte, Stefan Schulz, Deborah L. Segaloff, Charles N. Serhan, Arun K. Shukla, Khuraijam Dhanachandra Singh, Craig M. Smith, Nicola J. Smith, Claudia Stäubert, Leigh A. Stoddart, Yukihiko Sugimoto, Roger Summers, Valerie P. Tan, David M. Thal, Walter ( Wally) Thomas, Pieter B. M. W. M. Timmermans, Kalyan Tirupula, Lawrence Toll, Giovanni Tulipano, Hamiyet Unal, Thomas Unger, Celine Valant, Patrick Vanderheyden, David Vaudry, Hubert Vaudry, Joseph G. Verbalis, Jean‐Pierre Vilardaga, Christopher S. Walker, Ji Ming Wang, Donald T. Ward, Hans‐Jürgen Wester, Gary B. Willars, Tom Lloyd Williams, Trent M. Woodruff, Huixian Wu, Cheng Yang, Chengcan Yao, Richard D. Ye, Nathan Zaidman   +206 more
wiley   +1 more source

Substance Use and Problem Gambling Interventions for People With Intellectual Disability: A Systematic Review

Journal of Intellectual Disability Research, Volume 69, Issue 10, Page 1154-1171, October 2025.
ABSTRACT Introduction People with intellectual disability (ID) face increased vulnerability to addictive behaviours, yet effective interventions are under‐researched. This study aimed to systematically review existing interventions for substance use and problem gambling in this population. Methods Following PRISMA guidelines, we searched Web of Science,
Amalia Udeanu, Gloria Garcia‐Fernandez, Andrea Krotter, Juan Antonio García‐Aller, Patricia Solis Garcia, Laura E. Gómez   +5 more
wiley   +1 more source

Switching antipsychotics to aripiprazole or blonanserin and plasma monoamine metabolites levels in patients with schizophrenia

, 2014
ObjectiveBlonanserin is a novel atypical antipsychotic drug that has efficacy equal to risperidone. We investigated the effects of aripiprazole and blonanserin on clinical symptoms and plasma levels of homovanillic acid (pHVA) and 3-methoxy ...
Niwa, S. I., Mashiko, H., Yabe, H., Shiga, T., Miura, I., Kanno-Nozaki, K., Katsumi, A.   +6 more
core   +1 more source